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4. SYNOPIS 
Surgical procedures are associated with tissue injury and the majority of 
operated patients will experience some degree of pain after surgery. Many 
patients will suffer from moderate or even severe pain after the operation. 
Research has shown that poorly managed pain treatment may have both acute 
and chronic negative effects. Recovery after surgery may be prolonged by 
postoperative pain and complications may occur more frequently. 
This thesis contains three studies, which were conducted during 2006 and 2009 
at the Bærum Hospital, which is a tertiary teaching hospital near Oslo in 
Norway. All studies address research questions of improved postoperative pain 
control from a clinical point of view and were designed in a randomized 
controlled manner with a double blind design when possible. 
The first study showed that the analgesic drug S (+) ketamine, given during 
haemorrhoidectomy, had no beneficial effect regarding postoperative pain, 
when used on top of a multimodal pain regimen.  
The second study demonstrated that a single dose of the drug pregabalin, given 
one hour before surgery of the back, could reduce both preoperative anxiety, 
but also postoperative pain and the consumption of morphine after surgery. 
The last study evaluated the effect of a new analgesic concept, known as local 
infiltration analgesia (LIA), and was compared with epidural analgesia in 
patients undergoing total knee replacement. LIA resulted in reduced opioid 
consumption, faster mobilisation and earlier readiness for hospital discharge. 
The study also demonstrated that the analgesic drugs ketorolac and morphine 
were more efficient when given locally than systemically. 
The study results have been implemented into everyday clinical practice at the 
Bærum Hospital and may improve patient treatment and patient satisfaction.  
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5. SYNOPIS (Norwegian) 
Operasjoner er forbundet med vevsskade og nesten alle pasienter som 
opereres vil oppleve en viss grad av smerte etterpå. Mange pasienter lider av 
moderate til sterke smerter etter en operasjon. Forskningen har vist at 
smerteomfang og utilstrekkelig smertelindring i forbindelse med operasjoner 
kan ha negative effekter både på kort og lang sikt. Det kan også ta lengre tid til 
å bli frisk. 
Denne avhandlingen omfatter tre studier som ble gjennomført i årene 2006 til 
2009 ved Bærum Sykehus, et lokalsykehus i nærheten av Oslo. Alle studiene er 
basert på klinisk forskning og har fokus på forbedret smertelindring etter 
operasjoner. Studiene har vært randomiserte og kontrollerte, med dobbel 
blinding der det var mulig. 
Den første studien viste at pasienter som ble behandlet med det smertestillende 
medikamentet S (+) ketamin under operasjonen ikke hadde mindre vondt etter 
en hemorroide operasjon. 
Den andre studien demonstrerte at en tablett pregabalin, gitt en time før en 
ryggoperasjon, ikke bare reduserte preoperativ angst, men også smerter og 
bruk av morfin etter operasjonen. 
Den siste studien undersøkte effekten av et nytt smertekonsept som heter lokal 
infiltrasjonsanalgesi (LIA). LIA ble sammenlignet med epiduralanalgesi hos 
pasienter som fikk operert inn total kneprotese. Vi viste at LIA medførte mindre 
opioidforbruk, raskere mobilisering og at pasientene ble tidligere 
utskrivningsklare fra sykehuset. Studien demonstrerte i tillegg at de to 
smertestillende medikamentene ketorolak og morfin virker bedre når man gir de 
lokalt i kneet enn når man gir de intravenøst (systemisk).  
Resultatene fra disse studiene har blitt innført i den daglige kliniske praksisen 
ved Bærum Sykehus og forhåpentligvis fører det til bedre pasientbehandling. 
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6. INTRODUCTION 
The intensity of postoperative pain, the consumption of analgesics, the 
functional outcome and the incidence of adverse effects for some new 
analgesic treatment modalities after standard surgical interventions are the 
topics of this thesis. 
Surgery is always associated with tissue injury and almost all patients will 
experience some degree of postoperative pain after surgical interventions, in 
spite of conventional pain treatment. This is the reason for my research interest 
in this topic. 
To my knowledge, no data have been published regarding the incidence of 
postoperative pain or the efficacy of postoperative pain treatment in Norway. 
However, recent data suggest that at least 30-40% of all surgical patients do 
experience moderate or severe postoperative pain1. Further, there are studies 
in Norwegian cancer patients showing that many patients are suffering from 
moderate to severe pain without getting adequate pain relief2,3. International 
investigations on postoperative pain epidemiology confirm this. Fletcher et al. 
conducted a survey on postoperative pain management in France and found 
that nearly 90 percent of all patients reported postoperative pain after surgery. 
More than one quarter of the patients suffered from severe postoperative pain 
on movement and about four percent reported severe postoperative pain at 
rest4. Sommer et al. showed in a prevalence study of postoperative pain in the 
Netherlands that more than 40 percent of all patients suffered from moderate or 
severe pain at rest on the day of surgery5. Based on these studies, as well as 
on own clinical experience, one may assume that a significant proportion of 
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patients that undergo surgery in Norway still experience moderate to severe 
postoperative pain. 
The ultimate vision is to improve postoperative pain handling to the point that 
pain after surgery can be prevented and surgery becomes 'pain free'. 
The three studies in this thesis were conducted during 2006 and 2009 at the 
Bærum Hospital, which is a tertiary teaching hospital near Oslo in Norway. All 
research studies were designed in a randomized controlled manner with a 
double blind design when possible.  
All studies address research questions from a clinical point of view. As a 
consequence the study results may hopefully be implemented into everyday 
clinical practice and improve patient treatment and patient satisfaction.  
The layout of the present synopsis is made as suggested by a guideline for 
theses in Norway6.  
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6.1 The pathophysiology of pain 
The International Association for the Study of Pain (IASP) defines pain as: 
“An unpleasant sensory and emotional experience associated with actual or 
potential tissue damage, or described in terms of such damage”7. 
A surgical procedure causes nerve stimulation, tissue injury and damage of 
small nerve fibres. As a consequence histamine and inflammatory mediators 
are released. These inflammatory mediators include peptides (e.g., bradykinin), 
neurotransmitters (e.g., serotonin and ATP), lipids (e.g., prostaglandins), and 
neurotrophins (e.g., nerve groth factor)8,9. This “inflammatory soup” interacts 
with receptors or ion channels on sensory nerve endings (peripheral 
nociceptors) (Figure 1)8,10. Nociceptors may release peptides and 
neurotransmitters (e.g., substance P, calcitonin-gene-related peptide (CGRP) 
and ATP) locally when they are activated by noxious stimuli. This process is 
called neurogenic inflammation and induces vasodilatation and plasma 
extravasation (Figure 1)8.  
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Figure 1: The ’inflammatory soup’:  
Peptides (bradykinin), lipids (prostaglandins), neurotransmitters (serotonin (5-
HT) and ATP) and neurotrophins (NGF) are activated by tissue injury and lower 
the threshold (i.e., sensitization) or excite the terminals of the nociceptor by 
interacting with cell-surface receptors. Nociceptor activation transmits afferent 
messages to the dorsal horn of the spinal cord and further to the brain. 
Moreover the process of neurogenic inflammation may be initiated. 
Release of neurotransmitters, e.g., substance P and calcitonin gene related 
peptide (CGRP), form peripheral nerve terminals may induce vasodilatation, 
extravasation of plasma as well as activation of non-neuronal cells (e.g., mast 
cells and neutrophils). DRG = Dorsal Root Ganglion. 
Modified from Julius D. and Basbaum AL. Nature. 2001;413:203-210 (with 
permission)8. 
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The activation of peripheral nociceptors by noxious stimuli is termed 
transduction. Further delivery of noxious stimuli as an action potential from 
peripheral somatic and visceral sites to the dorsal horn of the spinal cord via Aδ 
and C nerve fibres is called conduction, whereas the synaptic transfer of 
noxious impulses to secondary-order cells in the dorsal horn is termed 
transmission (Figure 2)9,10. Transmission of nociceptive information undergoes 
complex modulation in the spinal cord.  
Pain-suppressive mechanisms take place locally within the dorsal horn and are 
mediated from higher levels of the brainstem and midbrain. Endogenous 
analgesic compounds, including enkephalin, norepinephrine, serotonin and 
gamma amino butyric acid (GABA), are released from spinal interneurons and 
terminal endings of inhibitory axons from supraspinal sites. Spinal modulation is 
mediated by the inhibitory actions of these endogenous analgesics9,10. 
Descending pathways in endogenous pain modulation may play an important 
role in the inhibition or promotion of noxious information. The term diffuse 
noxious inhibitory control (DNIC) describes the phenomenon that spinal 
neurons may be inhibited, often by spatially distant nociceptive stimulation11,12. 
Although some impulses pass to the ventral and ventrolateral horns and initiate 
segmental (spinal) reflex responses, it is assumed that most impulses are 
propagated to higher neuronal centres. This transmission is mediated via the 
spinothalamic and spinoreticular tracts and induces suprasegmental and 
cortical responses. This will finally lead to the perception of pain9. 
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Figure 2: Overview over pain perception 
A. Neural Transmission: Tissue trauma causes the release of noxious 
mediators, which activate the terminals of the nociceptor (1. Transduction). 
Noxious impulses are delivered to the dorsal horn of the spinal cord (2. 
Conduction) and via synaptic transfer to the central nervous system (3. 
Transmission). Spinal interneurons facilitate this noxious transmission (4. 
Modulation). CNS structures suppress pain transmission (5. Descending 
inhibition). 
B. Humoral transmission: Tissue injury results in humoral transmission of 
noxious mediators to the CNS. 
DRG = Dorsal Root Ganglion 
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Repeated or prolonged release of inflammatory mediators in the periphery may 
sensitize functional nociceptors. This sensitization is characterized by 
decreased activation threshold, increased discharge rate, and increased basal 
discharge. Furthermore, continuous nociceptive activity may activate dormant 
nociceptors and subsequently shift the dorsal horn to sensitised modes9,13,14. 
The phenomenon of neurohumeral alterations at the site of injury is called 
peripheral sensitization and may be responsible for primary hyperalgesia10,15. 
Hyperalgesia is defined as “an altered state of sensibility in which the intensity 
of discomfort associated with repetitive noxious stimulation is markedly 
increased”10. Intensive noxious stimulus from the periphery may also result in 
exaggerated dorsal horn responses to Aβ-fibre input14. This process is called 
central sensitization and will cause secondary hyperalgesia, which refers to an 
alteration in noxious sensitivity in nontraumatized regions10,15. 
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6.2 Postoperative pain 
Most surgical procedures are associated with tissue damage and the majority of 
operated patients will experience some degree of postoperative pain. After 
major surgery (e.g., hysterectomy), pain at rest is usually moderate during the 
initial two to three postoperative days and, in general, pain at rest reliefs within 
one week after the surgical procedure. In contrast to this, pain during activity 
(e.g., walking or coughing) is severe in many patients during the first 72 hours 
after surgery and pain intensity during activity will often remain moderate to 
severe for days and even longer16,17. 
Poorly managed postoperative pain may have both acute and chronic negative 
effects and may influence morbidity and mortality18-20. 
Transmission of painful stimuli from the periphery to the CNS causes 
neuroendocrine stress responses, which are characterized by an increased 
secretion of catabolic hormones including cortisol, catecholamines, 
adrenocorticotropic hormone, antidiuretic hormone, glucagon, aldosterone, 
renin and angiotensin II. Furthermore, anabolic mediators such as insulin and 
testosterone are inhibited9,10. 
Postoperative pain may activate the sympathetic nerve system. This 
sympathoadrenal stress response may increase myocardial oxygen 
consumption and decrease myocardial oxygen supply due to coronary 
vasoconstriction. In addition gastrointestinal activity may be decreased19. 
Acute postoperative pain may be followed by persistent, chronic postsurgical 
pain in 10 – 50 % of individuals after common surgical procedures, with 2-10 % 
of patients experiencing severe chronic postsurgical pain (Table 1)21. Chronic 
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post-surgical pain is defined as painful discomfort lasting for more than 2-6 
months after surgery, corresponding to pain persisting beyond the normal 
process of complete wound healing21,22. Postsurgical chronic pain may be either 
a result of ongoing inflammation or, probably frequently, an expression of 
neuropathic pain, which may be a result from peripheral nerve injury during 
surgery21. The risk of developing chronic pain may be associated with the 
intensity of acute postoperative pain22-24. Buvanendran et al. have recently 
shown that the administration of pregabalin, an antihyperalgesic drug, may 
reduce both epidural drug consumption after total knee arthroplasty, but also 
the incidence of neuropathic pain at three and six month25. Furthermore, it has 
been shown that preoperatively initiated epidural analgesia is associated with a 
lower incidence of chronic post-thoracotomy pain26. 
The intensity of postoperative pain may, to a certain degree, be predicted prior 
to surgery27-29 and various risk factors seem to influence the development of 
postoperative pain, e.g., age, gender, race, genetic polymorphism, as well as 
the intensity of preoperative pain and psycho-social aspects including anxiety 
and need for informaion30-35. 
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Table 1: Estimated incidence of chronic postoperative pain and disability after 
selected surgical procedures 
Type of surgery 
Estimated 
incidence of 
chronic pain 
Estimated chronic 
severe (disabling) pain 
(>5 out of score of 10) 
US surgical 
volumes* 
Amputation 30-50 % 5-10 % 159000 (lower limb only) 
Breast surgery 
(lumpectomy and 
mastectomy) 
20-30 % 5-10 % 479000 
Thoracotomy 30-40 % 10 % unknown 
Inguinal hernia repair 10 % 2-4 % 609000 
Coronary artery bypass 
surgery 30-50 % 5-10 % 598000 
Caesarean section 10 % 4 % 220000 
*National Center For Health Statistics, Ambulatory and Inpatients Procedures, 
USA, 1996.  
Modified form Kehlet H. et al. Lancet. 2006;367:1618-25 (with permission). 
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6.3 Principles of postoperative pain treatment 
There are many options available for treating pain after surgery, including 
systemic analgesia (i.e., opioid and non-opioid drugs), regional analgesic 
techniques (i.e., neuraxial and peripheral), local anaesthetic wound infiltration 
and a combination of these. It is important to assess the risks and benefits of 
each treatment modality. The goal is an optimized postoperative analgesic 
regimen for each individual patient. Furthermore, patients’ preferences have to 
be considered.  
Beside pharmacological interventions, non-pharmacological approaches (e.g., 
acupuncture, transcutaneous electrical nerve stimulation and psychological 
interventions) may be part of postoperative pain management (Figure 3). 
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Figure 3: The different options for postoperative pain management 
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6.3.1 Systemic analgesia 
Analgesic drugs may be divided into opioid and non-opioid drugs. The opioid 
drug class includes substances which bind to specific opioid receptors located 
throughout the central nervous system and other tissues36,37. The non-opioid 
drugs can be subclassified into specific and non-specific analgesics38. The 
specific drugs include paracetamol (acetaminophen) and non-steroidal anti-
inflammatory drugs (NSAIDs) which act as cyclooxygenase inhibitors (two 
isoenzymes COX-1 and COX-2). The non-specific drug group consists of drugs 
with analgesic properties that are commonly used for other purposes, e.g., 
treatment of depression or epilepsy. 
 
6.3.1.1 Opioids 
Traditionally opioid analgesics are one of the cornerstones in the treatment of 
moderate or strong postoperative pain. Opioids can be classified as naturally 
occurring, e.g., morphine, or as synthetic substances, e.g., fentanyl, 
pentazocine and methadone9. The opioids bind to several types of opioid 
receptors in the body, all belonging to a family of G-protein-coupled receptors39. 
Three major types of opioid receptor have been identified: μ (mu), κ (kappa) 
and δ (delta) 40,41. In addition a further opioid-like receptor has been identified, 
which was first named ORL1-receptor42 and later termed nociceptin orphanin 
FQ peptide receptor (NOP)43. 
As a general rule, most opioids exert their analgesic effects through μ-receptor 
binding in the central nervous system. However, opioids may also bind to opioid 
receptors in the periphery, when they are present 37,44. Their binding to the 
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different opioid receptors causes the different opioid drug effects. Morphine acts 
as an μ-agonist, whereas naloxone and naltrexone act as μ-, κ- and δ-opioid 
receptor antagonists. Pentazocine stimulates the κ-receptor. Buprenorphine is a 
partial μ-agonist (mixed agonist-antagonist)9. In general, clinical available pure 
μ-agonist opioids have a linear dose-response curve without ceiling of effect. 
They are therefore well suited for the management of postoperative pain, 
because opioids can be titrated intravenously until sufficient pain relief is 
obtained. The analgesic efficacy of opioids is typically limited by the occurrence 
of opioid-related side effects such as postoperative nausea and vomiting 
(PONV), constipation, sedation and respiratory depression9. One of the most 
common additional side effects of intrathecal and epidural administration of 
opioids is pruritus45, whereas urinary retention may also occur. 
Opioids are most commonly administered orally or intravenously. However, they 
may also be administered by the subcutaneous, transcutanous, intramuscular 
and transmucosal route9,46. In addition, opioids may be administered at specific 
anatomical sites e.g. neuraxial or intraarticular37,44,47-49. 
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6.3.1.2 Non-opioids 
6.3.1.2.1 Paracetamol (acetaminophen) 
Paracetamol is a well-established analgesic drug for the postoperative period 
and is associated with few adverse effects in routine dosing and practice50. The 
drug can be administered by the oral, the intravenous and the rectal route51,52. 
Paracetamol crosses the blood-brain barrier rapidly and is concentrated in the 
cerebrospinal fluid53. The onset of clinical action after IV infusion has been 
shown after 5-10 minutes, with a peak analgesic effect at about 1-2 hours54. 
In clinical practice, paracetamol is often the baseline drug of multimodal 
postoperative pain management (see later) as there is good evidence for its 
analgesic efficiency50,55,56. Although the analgesic potency is limited, studies 
have shown that paracetamol may reduce postoperative morphine 
consumption57. The mechanism of paracetamol analgesia is not completely 
understood, but it seems to act by inhibition of the prostaglandin synthesis in 
the central nervous system (figure 4)58. Therefore, paracetamol is claimed to be 
part of the non-steroidal anti-inflammatory drug class by some authors,9. 
Paracetamol seems to have effects both via peripheral and central 
mechanisms59. Paracetamol, given as a single dose of 1000 mg, has a number 
needed to treat (NNT) of 3.8 (CI 3.4 – 4.4) for at least 50 % pain relief in 
patients with moderate to severe pain60. The NNT is used to assess the 
effectiveness of a health-care intervention versus placebo, and the lower the 
NNT, the more effective is the treatment61. 
In clinical practice paracetamol may be used as premedication, e.g., 1000 – 
2000 mg paracetamol (according to bodyweight), orally about 1 hour prior to 
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surgery10,62. Intravenous paracetamol is well-suited for the perioperative period, 
e.g., 1000 mg63. In the postoperative period the medication with paracetamol is 
continued, e.g., 1000 mg every 6 hours64-66. In paediatric patients a 
preoperative dose of 20 - 40 mg/kg may be followed by 20 mg/kg four times a 
day postoperatively67. The combination of paracetamol with the opioid codeine 
has shown to reduce moderate to severe postoperative pain68. These two drugs 
have additive analgesic effect and reduce the NNT to 2.2 (CI 1.7 – 2.9)60.  
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6.3.1.2.2 Nonsteroidal anti-inflammatory agents 
The arachidonic acid cascade system (figure 4) plays a key regulatory role in 
cell physiology. Oxidation of arachidonic acid by the cyclooxygenase (COX) 
mediated pathway results in several prostaglandins and thromboxanes, many 
which influence the perception of pain69. Prostaglandins play an important role 
as mediators in peripheral sensitization and hyperalgesia. Nonsteroidal anti-
inflammatory drugs (NSAIDs) exert their analgesic effect through inhibition of 
cyclooxygenase and synthesis of prostaglandins9. 
At least two isoforms of the COX enzyme have been discovered: COX-1 and 
COX-2. COX-1 is expressed constitutively in many cell types and contributes to 
the natural homeostasis, whereas COX-2 is mostly induced at the site of 
inflammation, in the periphery and centrally70. COX-1 mediated prostaglandins 
facilitate in platelet aggregation, haemostasis and gastric mucosal 
protection71,72. COX-2 is involved in pain, inflammation, and fever73,74. A COX-2 
selective inhibitor would therefore, theoretically, reduce pain with little side 
effects. As a consequence selective COX-2 inhibitors have been developed75. 
However, the COX-2 isoenzyme is constitutive in some tissue such as kidney 
and lung and has a role in the complex mechanisms of cardiovascular disease. 
Thus, the possible benefit of COX-2 specificity is more limited than initially 
thought. Still, COX-2 inhibitors are associated with no bleeding tendency as well 
as less gastrictric mucosa side-effects compared to traditional, non-selective 
NSAIDs76-78. The analgesic efficacy of selective COX-2 inhibitors and non-
selective NSAIDs seems to be equivalent79-83. 
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Figure 4: Surgical trauma leads to initiation of a biochemical cascade:  
Cell membrane phospholipids are converted to arachidonic acid and 
oxygenation of arachidonic acid via the cyclooxygenase (COX) pathway 
generates a series of prostaglandins, thromboxanes and prostacyclines. 
Furthermore, arachidonic acid is converted to leucotrienes by lipooxygenase. 
NSAIDs and COX-2 inhibitors are thought to reduce pain by suppressing COX-
mediated prostaglandin E2. Corticosteroids suppress the action of 
phospholipase A2 and paracetamol suppresses substrate activation of COX. 
Modified from Dahl V. Doctoral thesis 2000 (with permission)69. 
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NSAIDs provide effective analgesia for mild to moderate pain when used as a 
sole agent84. Moreover, NSAIDs are considered to be a useful adjunct to 
opioids in the treatment of moderate to severe pain85,86. Several studies have 
demonstrated that NSAIDs may contribute to a reduction of opioid consumption 
after surgery87,88. However, it is debated if NSAIDs consistently reduce opioid-
related adverse effects in postoperative pain management88,89. 
NSAIDs may be administered orally or parenterally and are especially useful as 
components of a multimodal analgesic regimen9.  
The perioperative use of NSAIDs may also be associated with other side 
effects, including negative effects on osteogenesis and bone healing. NSAIDs 
are contraindicated in patients with known renal failure and should be used with 
caution in hypovolemic patients. However, a recent Cochrane review revealed 
that NSAIDs were not associated with a clinically relevant reduction in renal 
function in patients with normal preoperative function90. Regarding bone 
healing, animal studies have demonstrated that NSAIDs may inhibit the healing 
process of fractures in a special clinical.91-94. A recently published study showed 
that short-term use of moderate doses of ketorolac (< 120 mg/d) had no 
significant effects on the ultimate fusion rates in patients undergoing spinal 
fusion procedures95, whereas high-dose ketorolac (> 120 mg/d) increased the 
risk of non-union in this patient population96. 
The long-term use of COX-2 inhibitors has been associated with increased 
cardiovascular toxicity and as a consequence rofecoxib was withdrawn from the 
market in the year 2004. However, the cardiovascular risks of the different 
COX-2 inhibitors are variable and influenced by several factors such as specific 
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medication, dosage, and patient characteristics97,98. Also, often there is no 
clearcut and strict distinction between traditional NSAIDs and COX-2 inhibitors, 
as many classical NSAIDs also have a significant degree of COX- 2inhibition. 
Interestingly, the traditional NSAID diclofenac may be associated with a higher 
cardiovascular risk than the modern COX-2 inhibitor celecoxib, whereas the 
cardiovascular risk for other traditional NSAIDs, like naproxen and piroxicam, 
may not be increased98. This may be due to the different COX-1/COX-2 ratio of 
these drugs99. 
It is important to notice that bronchospasm may be induced by traditional 
NSAIDs (including aspirin), and there is a risk for cross-sensitivity with 
paracetamol in aspirin-sensitive asthmatic patients100. The use of COX-2 
inhibitors in asthma patients seems to be associated with less risk of 
bronchospasm101,102.  
Finally, it has to be mentioned that a part of the evidence concerning COX-2 
inhibitors was based on the publications of Scott Reuben103,104. In the year 2009 
more than 20 publications of this author were retracted due to research 
falsification and fabrication of data105-107. Therefore, further studies are needed 
to strengthen the evidence for the analgesic efficacy and safety of selective 
COX-2 inhibitors compared with non-selective NSAIDs. 
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6.3.1.2.3 Ketamine 
In the early sixties a phencyclidine (PCP) derivate was synthesized named 2 
(O-chlorophenyl)-2-methylamino-cyclohexanone or CI-581, “a powerful 
analgesic and anaesthetic with an unusual spectrum of pharmacologic 
effectiveness”108. This substance was subsequently known as ketamine, a 
racemic mixture of S (+) – and R (-) ketamine. The optical stereoisomer S (+) – 
ketamine has four times the affinity for the N-methyl-D-aspartate (NMDA) 
receptor than R (-) – ketamine and is clinically twice as analgesic potent as the 
racemic109,110. 
Ketamine interacts with several receptors and ion channels but is mainly an 
uncompetitive NMDA receptor antagonist111,112. NMDA receptor block prevents 
acute pain, and NMDA receptor mediated plasticity seems to play an important 
role in the development of central sensitization111,113-115. 
Traditionally, ketamine is known as a perioperative anaesthetic agent; lately, 
increasing interest in the use of low-dose ketamine for postoperative pain 
management has evolved. The NMDA-antagonistic properties of ketamine may 
attenuate opioid induced hyperalgesia (OIH) and opioid tolerance116,117. Various 
recently published studies have confirmed the antihyperalgesic effect of low-
dose ketamine after major orthopedic or abdominal surgery118-120. 
Several systematic reviews have shown that subanaesthetic doses of ketamine 
can reduce the intensity of postoperative pain and the consumption of 
opioids121-125. Low doses of ketamine are defined as an intravenous bolus of 
less than 1 mg·kg-1 and/or continuous intravenous infusion at rates below 20 
µg·kg-1·min-1 124. McCartney and co-workers concluded recently in a qualitative 
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systemic review that administration of NMDA receptor antagonists before and/or 
during surgery was able to reduce postoperative pain123. 
NMDA receptor activity is important for normal function of the central nerve 
system, and NMDA receptor antagonists like ketamine have psychotomimetic 
side effects which may limit its use111,126,127. Recently published studies have 
demonstrated that S (+) –ketamine may have less psychotomimetic side effects 
than racemic ketamine in non-surgical patients127,128, whereas surgical patients 
are not much studied in this context yet. 
In general, ketamine is administered intravenously or intramuscularly. Also, 
ketamine can be given epidurally, intrathecally, intraarticularly, as well as orally 
and topically129-136.  
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6.3.1.2.4 Gabapentin and Pregabalin (Gabapentinoids) 
Gabapentin was licensed for the treatment of epilepsy in Europe in 1993, based 
on its anti-spastic effects and efficacy in experimental seizure models137. The 
antinociceptive properties of gabapentin were discovered at a later stage138. 
Pregabalin is structurally related to gabapentin and has been marketed for the 
treatment of seizures and neuropathic pain in the UK since 2004. This drug has 
analgesic, antihyperalgesic, anticonvulsant and anxiolytic properties139-143. 
Originally, pregabalin was designed to be an analogue of GABA144. However, 
despite the name gabapentinoids, pregabalin neither interacts with the GABA 
receptor nor mimics GABA action139,145. In common with gabapentin, pregabalin 
binds to the α2-δ subunit of voltage-gated calcium channels localized 
particularly at synapses. Gabapentinoids may act by reducing the calcium influx 
via these presynaptic voltage-gated calcium channels. As a consequence, this 
may result in a decreased release of synaptic neurotransmitters (e.g., 
glutamate, norepinephrine, GABA, substance P). Gabapentinoids act as 
membrane stabilizers145-147. 
These drugs are only available for oral administration and the absorption of 
gabapentin is slow and limited by active transport in the gastrointestinal tract148. 
Plasma concentrations of gabapentin do not increase proportionally with 
increasing dose (non-linear absorption). In contrast, pregabalin absorption is 
more rapid and without a ceiling of amount absorbed. According to a first order 
kinetic, pregabalin absorption increases proportionally with increasing dose 
(linear absorption)149. In healthy volunteers peak plasma concentrations are 
achieved within one hour after the administration of pregabalin, whereas 
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maximum plasma concentrations for gabapentin are attained after 3-4 
hours141,149. The bioavailability of pregabalin is high and exceeds 90 percent 
irrespective of the dosage, whereas the bioavailability of gabapentin drops from 
60 percent to 33 percent as the dosage increases from 900 mg to 3600 mg 
daily149. For this reasons pregabalin has a favourable pharmacokinetic profile 
compared with gabapentin141,149. 
Gabapentin and pregabalin have proven efficacy in chronic neuropathic pain, 
e.g., diabetic neuropathy150-153, postherpetic neuralgia154,155, spinal cord injury156 
and phantom limb pain157. Furthermore, these two drugs may be helpful in the 
treatment of fibromyalgia158,159. 
Regarding acute pain, pregabalin and gabapentin act as antihyperalgesics and 
differ therefore from traditional antinociceptive drugs. Antinociceptive drugs, 
e.g., local anaesthetics, reduce the afferent input from intact and traumatized 
tissues, whereas antihyperalgesic drugs reduce the hyperexcitability of neurons 
located in the dorsal horn, which is caused by tissue injury160. Postoperative 
pain is commonly regarded as nociceptive (transient) pain. However, 
neurogenic, inflammatory and visceral mechanisms may contribute. Dahl et al. 
therefore define postoperative pain as “… a transient, or reversible, type of 
‘neuropathic’ pain”160. 
Several systematic reviews have consistently shown beneficial effects of 
gabapentin and pregabalin in reducing postoperative pain and/or postoperative 
opioid consumption161-164. 
In the systematic review by Ho et al., the gabapentin dosage given 
preoperatively varied between 300 mg and 1200 mg, and both low-dose and 
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high-dose regimens effectively reduced pain intensity and opioid consumption 
for the first 24 hours after surgery. In addition the incidence of PONV was 
reduced; but the level of sedation was higher in patients who were treated with 
gabapentin compared with placebo161. 
Different doses of preoperative pregabalin from 75 mg to 300 mg have been 
used in the literature 163-165. Although the majority have used a single dose of 
pregabalin given about one hour before surgery, there is some evidence that a 
repeated dose of pregabalin about 12 hours after surgery may be beneficial164. 
The administration of pregabalin is associated with side effects, especially when 
used in higher doses. Common adverse effects are dizziness, sedation, and 
visual disturbance164,166-168. However, pregabalin may reduce opioid-related 
adverse effects such as postoperative vomiting164. 
Gabapentinoids have anxiolytic properties142 and some studies have shown 
reduced preoperative anxiety with these drugs 169,170. Reduction in preoperative 
anxiety is good for the patient’s preoperative well-being and has been reported 
to be associated with decreased levels of postoperative pain29. 
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6.3.1.2.5 Glucocorticoids 
Glucocorticoids are naturally occurring hormones. Their secretion follow a 
diurnal rhythm and circulating levels are increased during trauma and stress10. 
They act by binding to nuclear corticosteroid receptors and genetic activation, 
which is associated with a significant latency to effect10,171. Systemic 
glucocorticoids have potent anti-inflammatory effects. Furthermore, this group of 
drugs has both analgesic and antiemetic properties172-175 with subsequent 
accelerated recovery after surgery 173,176,177. A recently conducted meta-
analysis demonstrated that a single perioperative dose of dexamethasone 
during adenotonsillectomy in paediatric patients resulted in a significant 
reduction in post-tonsillectomy pain178. The analgesic effect of glucocorticoids 
may be comparable to NSAIDs179,180, and a combination of glucocorticoids and 
NSAIDs seems to have an additive effect181-183. With a multimodal approach 
and baseline paracetamol medication, combining dexamethasone and rofecoxib 
(COX-2 antagonist) resulted in prolonged postoperative analgesia when 
compared to rofecoxib alone183. 
Romundstad et al. have recently shown that intravenous glucocorticoids may 
reduce the risk for chronic pain after breast surgery184. 
A systematic review of data from 1900 patients who underwent major surgery 
concluded that a single dose of methylprednisolon (up to 30 mg/kg) was not 
associated with any adverse effects185. Still, glucocorticoids interfere with the 
metabolism of glucose, with reports of somewhat increased blood glucose in 
the postoperative period186. 
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6.3.1.2.6 α2- Adrenergic receptor agonists 
The α2-receptor agonists have sedative, analgesic, anxiolytic and hemodynamic 
properties38. At least three different subtypes of the α2- adrenergic receptor 
have been identified, which may mediate sedation and antinociception 
separately187. Traditionally the α2-receptor agonists are mainly used to treat 
hypertension188 and opioid drug addiction189, but in later years the use of this 
class of drugs has expanded into the field of anaesthesia and analgesia190. This 
includes the use of α2-receptor agonists for peri- and postoperative pain relief, 
anxiolysis, sedation as well as treatment of chronic pain syndromes38,190. The 
analgesic effect of α2-receptor agonists is mediated by both peripheral and 
central mechanisms190. 
The α2-receptor agonists clonidine, dexmedetomidine and epinephrine are used 
in clinical anaesthesiologic practice. The receptor selectivity ratio for α2:α1 is 
1600:1 for dexmedetomidine, 200:1 for clonidine and 1:1 for epinephrine10,191.  
Clonidine may be administered intravenously, orally, intraarticularly intrathecally 
and epidurally47,192-194. Systemic administration of clonidine during surgery 
reduces both postoperative pain and opioid consumption195. A review regarding 
clonidine as an adjunct to local anaesthesia for peripheral nerve blockade 
showed improved analgesia duration196. Intrathecally administrated clonidine 
seems to have analgesic effect197, whereas the effects of epidural clonidine are 
inconclusive190. The injection of clonidine in joints has shown promising results 
regarding postoperative pain management198. 
The effect of dexmedetomidine on postoperative pain has not been much 
investigated compared with clonidine and most of the dexmedetomidine studies 
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address the sedative effect of this drug. However, a opioid-sparing effect of 
dexmedetomidine has been demonstrated190. 
Epinephrine is widely used as an adjunct for postoperative epidural analgesia 
and the synergistic pain relief with minor incidence of hemodynamic instability 
and motor block is well-documented10,199,200. Furthermore, epinephrine is used 
as an adjuvant to local anaesthetics in local infiltration analgesia (LIA)48,201-203. 
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6.3.1.2.7 Other analgesic adjuvants 
Neostigmine 
Endogenous acetylcholine levels can be increased by the inhibition of the 
acetylcholinesterase204. Neostigmine acts as a parasympathomimetic agent 
inhibiting cholinesterase in the synaptic area. Several studies have explored the 
use of neostigmine in anaesthesia and analgesia. Neostigmine may be 
administered intrathecally, epidurally, caudally and intraarticularly. In addition 
the drug may be used as adjuvant to local anaesthetics in peripheral nerve 
blocks10,205. Unfortunately, neostigmine affects the emesis centre in the brain 
stem and this results in a high incidence of nausea. The practical use of 
neostigmine as an adjunct is therefore limited.  Nausea occurs more frequently 
after intrathecal neostigmine compared to the other routes of administration205. 
Intraarticular neostigmine may have a beneficial effect regarding postoperative 
pain in patients undergoing arthroscopic knee surgery192,206. 
 
 
 
Nicotine 
Pain may be inhibited by acetylcholine action and the alkaloid nicotine interacts 
with ion channels of the nAChR family10,207. Smokers may have more 
postoperative pain than non-smokers, when they discontinue smoking due to 
hospitalisation208. Several studies have investigated if systemic nicotine could 
provide postoperative analgesia207, but there are also negative studies 
published209,210. Non-smoking patients undergoing uterine surgery received at 
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the end of surgery either 3 mg of nicotine by a nasal spray or placebo. Patients 
getting nicotine reported less pain during 24 hours as well as reduced morphine 
consumption211. Furthermore, transdermal nicotine patches applied before 
surgery in non-smoking patients resulted in improved analgesia after general 
surgery; although the opioid consumption was not reduced by nicotine in this 
study212. However, in smokers, transdermal nicotine patches failed to reduce 
postoperative pain209. 
Despite of these promising results more studies on nicotine analgesia in the 
clinical setting are needed. 
 
Magnesium 
Magnesium has antinociceptive properties due to its non-competitive blockade 
of the NMDA receptor. Moreover, magnesium is a physiological calcium 
antagonist at different voltage-gated channels213. Several clinical investigations 
have demonstrated that intravenous magnesium infusion during surgery can 
reduce postoperative pain214,215.  Furthermore, magnesium may be an effective 
adjuvant to both intrathecal and epidural anaesthesia due to its potential 
analgesic effect216,217. 
Magnesium has also been used as an adjuvant to intraarticularly administered 
local anaesthetics and showed analgesic effect comparable to intraarticular 
morphine218. 
However, a recently published systematic review investigating the analgesic 
effect of intravenous magnesium did not find convincing evidence that 
magnesium is beneficial in the management of postoperative pain213. 
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Cannabinoids 
Two cannabinoid receptors have been cloned (CB1 and CB2) and various 
proposed endocannabinoid ligands have been identified219,220. This has resulted 
in an extensive research and the development of cannabinoid agonists and 
antagonists10. Cannabinoids have been applied in clinical practice as a potent 
antiemetic in cancer chemotherapy patients221,222. 
Cannabinoids have antinociceptive properties in acute pain models in 
animals220. The analgesia produced by cannabinoids is generally modest. A 
recently conducted review of randomized controlled trials in humans concluded 
that the role of cannabinoids in the management of pain is questionable. 
Cannabinoids induce CNS depression and several adverse effects as 
drowsiness, dizziness, memory impairment and confusion are related to this 
class of drugs221.  
 
 
Capsaicin and the TRPV1-receptor 
The capsaicin receptor TRPV1 (transient receptor potential vanilloid 1) on C-
fibers is an emerging peripheral target for the treatment of pain. Capsaicin is the 
pungent chemical found in chilli peppers, and may elicit strong sensations of 
noxious heat and pain223. However, when the initial pain is vanishing, capsaicin 
may inactivate the TRPV1 fibers for days to weeks, and thereby producing 
selective C-fibre analgesia. Recently the FDA approved a dermal patch 
containing capsaicin to be applied after pretreatment with lidocaine. The 
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application of topical capsaicin may be beneficial in the treatment of pain, 
including neuropathic pain, and itch. Furthermore, perineural capsaicin 
injections may be useful in cancer patients with intractable pain224. 
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6.3.2 Regional Analgesia 
6.3.2.1 Neuraxial nerve blocks 
Neuraxial nerve blocks include spinal (subarachnoid), epidural and caudal 
nerve blocks. Depending on the dose, concentration and volume of local 
anaesthetic, this results in sympathetic blockade, sensory analgesia, or 
anaesthesia and block of the motor activity9. 
A systematic review has demonstrated that neuraxial nerve blocks may be 
associated with a lower incidence of complications (e.g., deep vein thrombosis, 
pulmonary embolism, pneumonia, myocardial infarction and renal failure). In 
addition, the overall mortality may be reduced225. 
However, neuraxial nerve blocks are also associated with rare complications 
caused either by the neuraxial procedure (e.g., needle and catheter placement 
and removal), or by the medication used for the blockade36,226,227. Permanent 
neurological complications after central neuraxial blockades can have severe 
consequences for the patient in question, although the general incidence is very 
low226-228. 
Local anaesthetics used for neuraxial nerve blocks include lidocaine, 
mepivacaine, ropivacaine and bupivacaine9. Vasoconstrictors, such as 
epinephrine and phenylephrine, may be added to prolong the action of the 
neuraxial blockade9,199 but may also have a specific analgesic action mediated 
by the alfa-2 agonist effect33,199,200. Moreover, adjuvants to local anaesthetics, 
e.g., opioids are frequently used in clinical practice47,229. 
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6.3.2.1.1 Spinal anaesthesia 
The spinal cord extends from the brainstem to the conus medullaris (L1 in 
adults, L3 in children); the subarachnoid space continues to S2/S39,36. Spinal 
anaesthesia acts by blocking nerve roots as they pass through the 
subarachnoid space and requires a small amount of local anaesthetic to provide 
complete sensory analgesia. A spinal nerve block should only be performed at 
the lumbar level in order to avoid trauma to the spinal cord230. Spinal 
anaesthesia is a common regional technique for surgical procedures below the 
umbilicus.  
 
6.3.2.1.2 Epidural anaesthesia and analgesia 
In contrast to spinal anaesthesia, epidural nerve blocks can be carried out at 
the sacral, lumbar, thoracic, or cervical levels. An epidural nerve block 
performed at the sacral level is called caudal nerve block and caudal epidural 
anaesthesia is a common regional procedure in paediatric patients36. Compared 
to spinal anaesthesia, larger amounts of local anaesthesics are necessary in 
epidural nerve blocks to provide profound analgesia9. 
There are many indications for epidural nerve blocks and the duration of 
analgesia can be prolonged by the insertion of an indwelling catheter. Analgesic 
effect can be obtained by the use of intermittent bolus doses, either controlled 
by the medical staff or by the patient himself (PCEA), and/or by a continuous 
infusion58. Epidural analgesia is very efficient for postoperative pain relief in 
patients undergoing major lower joint replacement231 major abdominal 
surgery232-234 or thoracotomy235-237. Moreover, perioperative epidural analgesia 
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may reduce adverse physiological responses to surgery238 and modulate 
immune function during surgery239. Some studies show that epidural nerve 
blocks may be beneficial regarding postoperative cardiovascular and pulmonary 
complications225,238,240, although the benefit seems to be limited to high-risk 
patients and high-risk procedures20,241,242. Thoracic epidural analgesia 
differentiates from lumbar epidural analgesia due to more profound sympathetic 
block, which promotes coronary perfusion and gastrointestinal motility243,244. 
Beattie et al. have shown, that postoperative thoracic epidural analgesia may 
reduce the incidence of postoperative myocardial infarctions to a greater extend 
than lumbar epidural analgesia245. This may be caused by improved balance of 
oxygen supply and demand in the ischemic heart243. Furthermore, thoracic 
epidural analgesia may be superior to lumbar epidural analgesia regarding the 
incidence of postoperative pneumonia225. This is probably due to the beneficial 
effect of thoracic analgesia on postoperative breathing and coughing243. Lumbar 
epidural analgesia may more frequently be associated with motor block of the 
lower extremities and urinary retention than thoracic epidural analgesia246,247.  
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6.3.2.2 Peripheral nerve blocks 
Blocks of peripheral nerves may be used for anaesthesia during surgery, either 
alone or in conjunction with general anaesthesia, or central neuraxial blocks. 
Furthermore, peripheral nerve blocks are commonly used for postoperative pain 
control, and for acute and chronic pain management36.  
Electric nerve stimulation and/or the use of ultrasound facilitate the identification 
of peripheral nerves248-251. 
Peripheral nerve blocks include blocks of the head, neck and trunk. Surgical 
anaesthesia of the shoulder and the upper extremity can be achieved by neural 
blockade of the brachial plexus (C5-T1) or its cords and terminal branches36,249. 
Lower limb nerve blockades are practised less frequently than upper limb 
blocks. The reasons for this are that it is impossible to block the whole lower 
limb with one injection and that neuraxial techniques may prove simpler58. 
Different approaches and techniques are used to carry out lower limb blocks in 
clinical practice252. Especially in major lower joint surgery, e.g., total knee 
arthroplasty (TKA), peripheral nerve blocks are frequently used. The femoral 
nerve block with or without a sciatic nerve block is suitable for postoperative 
pain treatment after TKA, either as a single shot injection, or as a continuous 
infusion253. Both single shot injections and continuous peripheral nerve blocks 
can be used for the management of peri- and postoperative pain and are 
associated with accelerated patient recovery and reduced length of hospital 
stay254. 
For surgical anaesthesia the choice of local anaesthetic (e.g., lidocaine, 
mepivacaine, ropivacaine, bupivacaine) for a peripheral nerve block depends 
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on the duration of the surgical procedure and need of strong postoperative 
analgesia. For prolonged nerve blockade, including postoperative pain 
management, long-acting agents such as bupivacaine, levo-bupivacaine or 
ropivacaine are often preferred9. Vasoconstrictors, usually epinephrine, are 
frequently added to the chosen local anaesthetic to fasten the onset of action 
and decrease systemic toxicity of local anaesthetics. Various adjuvants have 
been reported to improve duration and quality of the nerve blockade, e.g., 
opioids, clonidine, ketamine and neostigmine9,255. However, the effects of 
adjuvants in peripheral nerve blocks are controversial in the literature47. 
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6.3.2.3 Local anaesthetic infiltration 
Infiltration of local anaesthetics (LAs) into surgical wounds is a simple method to 
provide postoperative analgesia. The basic concept of this technique is to block 
pain at the origin due to local application of anaesthetics. LAs block voltage-
gated sodium channels and as a consequence the transmission of pain from 
the surgical wound is reduced or abolished. In addition the inflammatory 
response to the injury is suppressed222. 
In minor surgical procedures, e.g., herniotomy, the efficacy of incisional local 
anaesthetics regarding postoperative pain has been demonstrated several 
years ago256. Moreover, the use of local anaesthetics injected intraarticularly for 
pain relief has shown beneficial effect in orthopaedic surgery49,257-259. However, 
a single injection of LAs into the surgical wound is unlikely to have long-lasting 
effects. This is why new techniques for wound infiltration have been developed 
during the last decade260. 
The insertion of indwelling catheters at the end of surgical procedures has 
established new properties for the use of LAs, and facilitates the use of this 
technique in more extensive surgical procedures. These catheters can be 
placed into the incision, around a fascia, intraabdominally and intraarticularly. In 
clinical practice a bolus injection via the catheter at the end of surgery is often 
followed by either intermittent injections or a continuous infusion of local 
anaesthetics261-263.  
Dahl and Møiniche (2009) have recently published a review regarding the 
efficacy of topical local anaesthetic infiltration on pain relief in patients 
undergoing major abdominal surgery, e.g., abdominal hysterectomy and open 
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colonic surgery. They concluded that about half of the studies regarding 
hysterectomy and only one study about colonic surgery showed a beneficial 
analgesic effect261. Furthermore, Kim et al. recently published data where they 
have compared intraperitoneal lidocaine with intravenous lidocaine in patients 
undergoing laparoscopic appendectomy. They concluded that both treatment 
modalities were equally effective regarding postoperative pain and opioid 
consumption264.  
Another technique that is called local infiltration analgesia (LIA) has recently 
been introduced in major orthopaedic joint surgery261. The infiltration analgesia 
techniques for total knee and total hip arthroplasty (TKA and THA) were 
developed by Bianconi et al.265 and Kerr and Kohan201 in the beginning of this 
millennium. This approach involves the administration of large volumes of dilute 
local anaesthetics, e.g., ropivacaine, with or without adjuvants into different 
tissue structures during orthopaedic surgery. 
At the end of surgery the orthopaedic surgeon can place an indwelling catheter 
into the artificial joint, which makes it possible to prolong the analgesic effect by 
refilling local anaesthetics through this catheter in the postoperative period (top-
up dose)202,203,266. 
Various adjuvants can be added to the LIA mixture, e.g., epinephrine, ketorolac 
and morphine48,267. 
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6.3.3 Non-pharmacological approaches 
With the goal to provide the best postoperative pain regimen with the least 
number of associated adverse effects, all analgesic approaches have to be 
considered. Many non-pharmacologic analgesic techniques have their origin 
from eastern medicine practices. Acupuncture may be best known and has 
been used for more than 2500 years268. Acupuncture is based on a theory of 
interconnectedness where one energy source is spread throughout the universe 
and all things within it. The energy flow, which is called qi, remains balanced 
between the forces of yin and yang. The pathways for this energy flow are 
termed meridians. The human body is composed of several traditional 
meridians with more than 360 specific acupuncture points. The stimulation of 
these acupuncture points with needles may relieve obstructed flow of qi10,268. 
Regarding the use of acupuncture in the management of postoperative pain, 
Sun et al. recently have conducted a systematic review and concluded that 
perioperative acupuncture may be a useful adjunct. They demonstrated 
reduced opioid consumption, decreased postoperative pain intensity and a 
lower incidence of opioid-related adverse effects in patients who were treated 
with acupuncture269. However, it may be difficult to interpret the results of most 
of the studies, because of blinding issues and heterogeneity of the reviewed 
studies270. Moreover, several studies have been published with negative results 
of acupuncture 271-274. 
Transcutaneous electrical nerve stimulation (TENS) was developed about 40 
years ago and uses either low- (acupuncture-like) or high-frequency electric 
pulses. These pulses are applied by plaster electrodes, which are placed 
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transdermal near painful areas, the site of surgery, or peripheral nerves. The 
mechanism of action is thought to be a reduction of anterograde nociceptive 
transmission caused by an activation of GABA and opioid receptors on the 
spinal level270. Overall, there is more evidence for the efficacy of TENS on 
postoperative pain compared to acupuncture. DeSantana and co-workers 
recently have demonstrated in a prospective, double-blinded, randomized trial 
that high-frequency TENS reduced both postoperative pain and postoperative 
analgesic requirements in patients undergoing inguinal herniorrhaphy275. 
Furthermore, analgesic efficacy of TENS has been shown after laparoscopic 
and cardiac surgery276,277. 
Psychological interventions may be useful in the management of postoperative 
pain. Devine has shown in a quantitative review that psychological 
interventions, like health care relevant information, skills teaching and 
psychosocial support, may have a beneficial effect on pain intensity, 
psychological distress and recovery278. Adequate patient information plays an 
important role in pain management. Kalkman et al. have recently shown that a 
strong information seeking behaviour before surgery may reduce the incidence 
of severe postoperative pain29. However, some patients may habitually cope by 
avoiding detailed information279. Psychosocial support includes the identification 
of patient concerns before and after surgery, the encouragement of the patient 
to ask questions throughout the hospital stay and the provision of appropriate 
reassurances278. 
Another non-pharmacological approach in postoperative pain management is 
attentional control. Distraction from an acute pain stimulus by conversation or 
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music may help to reduce pain intensity279. Good et al. demonstrated that 
relaxation and music therapy reduced pain intensity after major abdominal 
surgery280. Hypnosis may be defined as an altered state of awareness10. By 
suggestion through a hypnotist, the patient may experience various changes in 
sensation, perception, cognition or control over motor behavior281. Montgomery 
et al. have conducted a meta-analysis and concluded that hypnosis may be 
useful for surgical patients282. 
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6.4 Pre-emptive and preventive analgesia 
The term pre-emptive analgesia describes an “antinociceptive treatment that 
prevents establishment of altered processing of afferent input, which amplifies 
postoperative pain”283. Various studies have been conducted comparing pre-
incisional analgesic treatment with post-incisional pain management. Meta-
analyses have shown conflicting results regarding the efficacy of pre-emptive 
analgesia284,285. While Ong and colleagues have demonstrated a beneficial 
effect of pre-emptive epidural analgesia, local anaesthetic wound infiltration and 
the administration of NSAIDs285, Moiniche et al. failed to find evidence for the 
pre-emptive effect of both local anaesthetic wound infiltration and NSAIDs284. 
A few years ago, the term preventive analgesia was introduced286,287. In 
contrast to a typical pre vs. post design (pre-emptive analgesia), in preventive 
analgesia the analgesic treatment is compared to another treatment given after 
the nociceptive stimulation is initiated. A preventive analgesic effect is present, 
when the observed effect (e.g., postoperative pain or reduced rescue analgesic 
consumption) exceeds the expected traditional duration of the analgesic 
agent288. It has been proposed that not the timing, but the duration of pain 
management may play an important role for the prevention of central 
sensitization and hyperalgesia286,287. Loco-regional techniques and different 
classes of drugs, e.g., NMDA receptor antagonists and gabapentin may have 
antihyperalgesic properties and may therefore be useful in a preventive 
analgesic strategy in the peri- and postoperative period123,161,289. 
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6.5 Multimodal analgesia 
Pain is caused by various mechanisms at various levels in the nervous system. 
In theory, the combination of different analgesic drugs and techniques should 
improve the efficacy of pain management by acting on different mechanisms 
and levels of action. Moreover, patient safety may be improved because, in 
general, reduced drug doses of each drug when combined are accompanied 
with a reduction of dose-dependant adverse effects. This type of pain 
management strategy is called multimodal or balanced analgesia64,290,291. 
However, despite all evidence for the efficacy of multimodal analgesic 
approaches292,293, these techniques seem underused in clinical practice294. In 
order to identify the most suitable multimodal analgesic strategy, a procedure-
specific approach is recommended291. The reason for this is that one analgesic 
technique, e.g., continuous epidural analgesia, may be beneficial in a specific 
type of major abdominal surgery (e.g., open colonic surgery), while being 
inappropriate in other types of abdominal surgery (e.g., nephrectomy). 
Moreover, different surgical procedures are associated with various 
complications (e.g., postoperative bleeding) and therefore the multimodal pain 
management has to be tailored according to this291. 
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7. HYPOTHESES 
 
1. Multimodal analgesia in the perioperative period leads to a reduction of 
postoperative pain (papers I + II) or decreased postoperative opioid 
consumption or both. (Paper II) 
 
2. Preoperative anxiety is associated with postoperative pain and preoperatively 
administered pregabalin can reduce anxiety before surgery. (Paper II) 
 
3. Multimodal antinociceptive treatment with S (+) ketamine or pregabalin is not 
associated with an increased frequency of adverse effects. (Papers I-II) 
 
4. Local infiltration analgesia (LIA) for total knee replacement can reduce post-
operative pain and opioid consumption compared to epidural analgesia. 
Furthermore mobilisation can be fastened and the hospital stay can be 
shortened. (Paper III) 
 
5. Local infiltration of ketorolac and morphine during total knee arthroplasty is 
more effective than systemic administration of these drugs. (Paper III) 
 
6. Local infiltration analgesia compared to epidural analgesia is not associated 
with an increased frequency of adverse effects. (Paper III) 
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8. METHODS 
8.1 Study design 
Research studies might either have a prospective or a retrospective design. A 
prospective study looks forward in time, and the study is designed before data 
is collected. In contrast, retrospective studies look backwards and the data 
collection is already finished at the start of the study. A prospective study 
design allows the researcher to include a control group (e.g., alternative or 
placebo treatment) and this may eliminate many confounding variables. Study 
participants can be followed throughout the whole study period to measure the 
outcome in question. The strength of evidence, which is derived from 
prospective studies, is higher than from retrospective studies. However, in 
prospective study design, data collection is more time-consuming and 
expensive. Furthermore, if the outcome is uncommon, the size of prospective 
investigation that is required to draw conclusions is often too large to be 
feasible and a retrospective design may be more suitable in these cases. 
When choosing study design in this thesis, the prospective approach for all 
three studies was regarded to be most suitable, because different treatment 
modalities were compared. Important data may often be non-available in a 
retrospective design. Furthermore, it is also difficult to control bias and 
confounders. 
Randomization of the study population is used to eliminate selection bias and to 
assure similar treatment groups. The purpose of randomization is to ensure that 
only one, controlled variable is different between two or more treatment groups. 
As a result of the randomization causalities can be attributed. Different 
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randomization techniques are in use: simple randomization (flipping a coin), 
block randomization (insure that the numbers of participants allocated to each 
treatment is not far out of balance) and stratified randomization (additional 
factors, e.g., gender or age, are balanced between the groups). 
RCTs are considered to be the most reliable form of scientific evidence295. Non-
randomization is afflicted with bias and this weakens the scientific evidence of 
the study. 
Randomization of the study participants was regarded to be important when 
planning this thesis and all three studies are randomized controlled trials (RCT). 
Permuted block randomization was carried out by the hospital pharmacy of the 
Asker and Bærum Hospital for all three studies. 
Blinding of the study participants and the observers (double blinding) is an 
attempt to eliminate subjective bias and results in more reliable data and 
strengthens the scientific evidence. Two clinical trials of this thesis (papers I and 
II) have been conducted in a double-blinded manner.  For the knee study, which 
is described in paper III, the study design was double-blinded for the two groups 
that were treated with local infiltration analgesia. Participants who were 
randomized to the epidural group were regarded as not fully blinded, as study 
participants and/or investigators might have realized if they got an epidural 
puncture or not.  
All studies included in this thesis were conducted in accordance to the 
Declaration of Helsinki and conformed to the CONSORT guidelines296,297 with 
written informed consent of all study participants. 
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8.2 Study approval and registration 
The National Committee for Medical and Health Research Ethics in Norway and 
the Norwegian Medicines Agency have approved all studies in this thesis before 
study start. 
All three studies were registered at http://clinicaltrials.gov before patient 
enrollment (paper I: NCT00354029, paper II: NCT00353704, paper III: 
NCT00562627). ClinicalTrial.gov is a worldwide registry of clinical trials hosted 
from the U.S. National Institutes of Health298. 
Collection of data and data analysis of the knee study (paper III) have been 
externally monitored (Section for Good Clinical Practice, Oslo University 
Hospital, Ullevaal). 
 
8.3 Participants 
Adult persons (≥ 18 years), ASA grade I+II (paper I) and ASA grade I-III (papers 
II + III) were enrolled with written informed consent. Exclusion criteria for all 
three studies were moderate or severe heart, liver, kidney, or psychiatric 
disease, pregnancy and breast-feeding. Participants with regular use of opioids 
and participants not understanding Norwegian were also excluded from 
participation. Patients with a history of gastric ulcer disease (all papers) or 
glaucoma (only paper I) were not included into the studies. 
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8.4 Surgical procedures, anaesthesia and analgesia 
Participants in paper I were scheduled for day-care haemorrhoidectomy. 
Patients in paper II were undergoing elective lumbar single-level discectomy 
and the participants in paper III were operated with unilateral total knee 
replacement. 
Total intravenous anaesthesia (TIVA) with propofol and remifentanil was used 
in two of the studies (paper I+II), whereas patients undergoing total knee 
arthroplasty (paper III) received spinal anaesthesia. 
Paracetamol was administered to all patients as premedication and every six 
hours postoperatively. All patients were observed in the post-anaesthestic care 
unit (PACU) after completed surgery. Participants undergoing discectomy 
(paper II) were treated with diclofenac 50 mg three times daily during the 
hospital stay. 
Patients scheduled for day surgery (paper I) were given an envelope containing 
analgesics and an information letter on how the medication should be taken. In-
hospital patients (paper II+III) were equipped with an IV patient-controlled 
morphine pump (PCA) for the first 24 hours (paper II) or 48 hours (paper III). 
Postoperative nausea and vomiting (PONV) was treated with IV odansetron 4 
mg and IV metoclopramide 10 mg. 
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8.5 Treatment comparisons 
Paper I: 
Participants in this study were randomized to either perioperative IV S (+) 
ketamine or placebo. 
After insertion of the laryngeal mask, but before start of surgery, patients in the 
S (+) ketamine group received an intravenous bolus dose of 0.35 mg· kg-1 S (+) 
ketamine (Pfizer, 2.5 mg·ml-1) followed by continuous infusion of 5 µg·kg-1·min-1 
S (+) ketamine. Patients in the placebo group received an equivalent volume of 
isotonic saline (bolus and infusion). Continuous infusion was stopped two 
minutes after end of surgery. Following the concept of multimodal analgesia, all 
patients received intravenous 8 mg dexamethasone and 30 mg ketorolac 
perioperatively. After completion of surgery the surgeon injected local 
anaesthesia (10-20 ml bupivacaine 2.5 mg·ml-1 + epinephrine 5 µg·ml-1) in the 
surgical field. 
 
Paper II: 
Participants in this study were randomized to receive either oral pregabalin 150 
mg, or an identically looking placebo capsule about one hour before surgery. 
 
Paper III: 
Patients were randomized to receive either postoperative epidural analgesia for 
a 48-hour period or to receive local infiltration analgesia. Patients getting local 
infiltration analgesia were further randomized in two groups and got, in addition 
to standard local infiltration analgesia, both ketorolac 30 mg and morphine 5 mg 
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injected either into the knee or intravenously. The standard local infiltration 
mixture (150 ml) contained 150 mg ropivacaine and 0.5 mg epinephrine added 
to isotonic saline. This mixture was injected peri- and intraarticularly by the 
orthopedic surgeon during total knee arthroplasty. In addition a catheter was 
placed into the knee joint at the end of operation. An intraarticular re-injection 
via this catheter with ropivacaine 142.5 mg and either intraarticular or IV 
ketorolac 30 mg was given 22-24 hours after surgery. The knee catheter was 
removed immediately after injection. 
Patients randomized to epidural analgesia got epidural infusion with 2 µg·ml-1 
fentanyl, 1 µg·ml-1 epinephrine, 1 mg·ml-1 bupivacaine started as soon as the 
spinal anaesthesia started to wear off. The infusion rate was programmed 
according to body height. 
 
8.6 Outcome measures 
The outcome measures used in this thesis are preoperative anxiety, 
postoperative pain, opioid consumption, time to mobilization and hospital 
discharge, as well as the occurrence of adverse effects. 
The scientific measurement of anxiety and pain is challenging, since both 
anxiety and pain are subjective experiences. Nevertheless, several methods for 
the assessment of acute pain have been developed and are used in both 
clinical and research practice. 
The visual analogue scale (VAS) uses a straight, non-graded line with the 
extremes of intensity on either end. The VAS can be used for the assessment 
of the intensity of both anxiety and pain. Typically a 100 mm ruler is used to 
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determine VAS. One end is defined as “not at all”, while the other end is defined 
as “worst imaginable”. The participants are asked to indicate the point on this 
line, which describes the intensity that they are currently experiencing. 
Thereafter the investigator measures the distance between the marked place by 
the participant and the zero-point in millimeters or centimeters. Some VAS-
rulers use words or faces along the scale to help the participant to better assess 
the intensity228. 
The numeric rating scale (NRS), where intensity is ranged from 0-10 and 0 
refers to “not at all” and 10 indicates “worst imaginable”, can also be used to 
assess pain and anxiety. The NRS may be more practical than the VAS 
because it can be used to assess the intensity of pain also during telephone 
interview228. 
Verbal rating scales (VRS) assess intensity using a list of words describing the 
intensity. Traditionally this kind of scales contains three to five categories. A 5-
point rating scale may consist of adjectives like none, mild, moderate, severe 
and very severe. The participant chooses the most appropriate word for the 
present experience. When comparing VAS, NRS and VRS, Breivik et al have 
shown that the power to detect a difference in pain intensity was higher with the 
NRS and the VAS data when compared with the VRS data299. However, 
especially in the elderly, the VRS is a well applicable tool for the registration of 
pain intensity300. 
Regarding the measurement of pain it is important to measure pain both at rest 
and also during movement and/or function as shown in a recently published 
systematic review301. Minimization of pain during movement is an important 
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clinical issue in terms of getting the patient mobilized and accessible for 
physiotherapy as well as resumption of normal level of activity. Pain 
assessment should be procedure specific and pain registrations during well-
defined and relevant function are essential302. 
 
8.6.1 Measurement of anxiety 
Preoperative anxiety was determined in participants undergoing lumbar 
discectomy (paper II) before induction of anaesthesia using an 11-point (0-10) 
visual analogue scale (VAS) ranging from “not at all anxious” to “extremely 
anxious”. Alternative instruments to measure anxiety are the Amsterdam 
Preoperative Anxiety or Information Scale (APAIS) and the state component of 
the State-Trait Anxiety Inventory (STAI). The APAIS consists of six questions 
asking about patients’ worries regarding anaesthesia and surgery as well as 
asking about patients’ requires for information303,304. The STAI presents 20 
statements describing anxiety states and the participant gives a score ranging 
from 1-4 for each statement305. 
  
8.6.2 Measurement of pain 
Pain intensity was assessed during the stay in the PACU and either during the 
stay on the surgical ward (paper II+III) and/or by telephone interviews (paper 
I+II). During the hospital stay the visual analogue scale (VAS) was used in all 
patients. In addition the numeric rating scale (NRS) was used in paper I and II, 
whereas a verbal rating scale was used in paper II and III. Postoperative pain 
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was assessed at rest in all study participants. Pain during movement was 
assessed differently in the conducted studies: 
In patients who underwent haemorrhoidectomy (paper I), NRS was used to 
assess pain during sitting and defecation at seven days after surgery. In 
participants who were operated with lumbar discectomy (paper II), VRS was 
determined during mobilization one week after surgery. Patients undergoing 
total knee replacement were asked about pain intensity (VAS and VRS) during 
active 45-degree knee flexion at several time points during their hospital stay. 
 
8.6.3 Measurement of the consumption of analgesics 
In paper I, study participants were treated with rescue pain medication when 
pain excided VAS > 30, NRS > 3 or upon patient request. Rescue analgesics 
were fentanyl 0.05-0.1 mg IV during the first 30 minutes after surgery and a 
combination of oral paracetamol 500 mg and codeine 30 mg later on. 
Consumption of rescue pain medication was recorded for the PACU period and 
after hospital discharge. 
In papers II and III all patients were equipped with an IV patient-controlled 
morphine pump (PCA) for either 24 hours (paper II) or 48 hours (paper III). The 
PCA was programmed to deliver 2 mg morphine on demand with 10 minutes 
lockout time. Total PCA morphine consumption was recorded. Patients 
undergoing TKA (paper III) received 10 mg oral slow release oxycodone twice a 
day and 5 mg standard oxycodone on request (rescue analgesic medication) 
from the third postoperative day. Cumulated oxycodone consumption was 
registered. Furthermore, cumulated opioid consumption during the first 72 hours 
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after surgery was calculated adding total PCA morphine consumption and total 
oxycodone consumption. A 1:1 ratio in analgesic potency between IV morphine 
and oxycodone was presumed as shown by Silvasti et al306. 
  
8.6.4 Measurement of function: 
Functional outcome was measured in patients who were scheduled for total 
knee arthroplasty (paper III). The physiotherapist assessed the active and 
passive range of motion of the knee joint after surgery. Furthermore the 
achieved walking distance on day first and second postoperative day was 
recorded. Each postoperative day discharge readiness was assessed by an 
orthopaedic surgeon, a pain nurse, a ward nurse and a physiotherapist 
according to the following criteria: no evidence for surgical complications, VAS 
pain at rest ≤ 30, which is controlled by oral analgesics, ability to eat and drink 
and ability to walk with elbow crutches and to climb ≥ 8 stairs. 
 
8.6.5 Measurement of adverse effects: 
Postoperative nausea and vomiting (PONV) was assessed in all patients 
postoperatively. Furthermore hypotension (systolic blood pressure <80 mmHg), 
dizziness and respiration depression were registered in all patients who were 
equipped with a PCA (paper II+III). Patients scheduled for haemorrhoidectomy 
(paper I) were postoperatively asked if they experienced abnormal colour 
vision, double vision or hallucinations to detect potential adverse effects related 
to S (+) ketamine. In patients undergoing lumbar discectomy (paper II), known 
side effects of pregabalin as sedation, pruritus, urinary retention and headache 
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were recorded in the postoperative period. In patients who were operated with 
total knee arthroplasty (paper III), muscle weakness during mobilization was 
registered. 
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8.7 Statistical analysis 
Power calculations were carried out for all three studies of this thesis and the 
intensity of postoperative pain was defined as the primary endpoint in each of 
the studies. Two of the papers (I and II) compared two groups, whereas paper 
III examined three different treatment modalities. 
The primary end point for the S (+) ketamine study (paper I) was the NRS pain 
intensity during the first postoperative day. In paper II, the pregabalin study, the 
VAS score for pain at rest 120 minutes after surgery was defined as the primary 
endpoint. In the knee study, paper III, mean VAS (at rest or at knee flexion) 
about 48 hours after total knee arthroplasty represented the primary endpoint of 
the study. 
The distribution of data was assessed with frequency histograms in all three 
studies. For comparisons of normally distributed data among two treatment 
groups (papers I+II), student t-test was used. Mann-Whitney U test was used 
for non-normally distributed data. Non-parametric variables were analysed with 
Kruskal-Wallis test, Chi-square test and Fisher’s exact test (papers I+II). Mean 
area under the curve (AUC) comparisons and Pearson’s correlations were used 
in paper II. 
For tests of differences in continuous variables between three groups (paper 
III), one-way ANOVA tests were used. Pairwise comparisons were done with 
Bonferroni correction. The distributions of all dependent variables were 
examined to assess the appropriateness of using parametric tests. 
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Categorical data were analyzed with chi-squared tests and Kruskal-Wallis tests 
adjusted for ties. Analyses for mean effects over repeated measurements 
(longitudinal data) were performed with linear mixed models.  
For data analysis SPSS® (version 16.0 – 18.0), StatXact 8 (Cytel inc., 2007) 
and CIA (www.som.soton.ac.uk/cia) were used. 
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9. RESULTS 
The results from the three studies in this thesis are presented according to the 
hypotheses. All studies have been conducted at the Bærum Hospital (Vestre 
Viken HF, Norway) in the time period between 2006 and 2009. Demographic 
data were comparable for the different groups in the respective papers. 
 
1st Hypothesis: Multimodal analgesia in the perioperative period leads to a 
reduction of postoperative pain (papers I + II) or decreased postoperative opioid 
consumption or both. (Paper II) 
 
In paper I, seventy-seven participants scheduled for haemorrhoidectomy were 
enrolled in this randomized, double-blind, controlled study and received either 
perioperative IV S (+) ketamine or placebo. 
Pain scores (NRS and VAS) did not differ significantly between the groups at 
any time points. Less than 10% of the patients had VAS ≥ 30 or NRS ≥ 3 during 
the PACU period. The pain scores (worst NRS during the sixth postoperative 
day) reported by telephone interview seven days after hospital discharge did 
not differ significantly between the groups but were markedly higher than 
reported in the previous interviews. This was mainly due to reports of pain 
during defecation. The majority of all study patients reported “no pain” during 
the interview after three months.  
 
 80 
In paper II, 50 participants undergoing lumbar discectomy were enrolled in this 
randomized, double-blind, controlled study and received either preoperative oral 
pregabalin 150 mg or placebo. 
The pain scores at rest (VAS) were significantly lower in the pregabalin group at 
120 min after surgery. There was a 34.5 percent reduction in the mean area 
under the curve (AUC) for VAS pain at rest in the pregabalin group during the 
PACU period (p = 0.011) and morphine consumption was higher in the placebo 
group. Pain scores and morphine consumption did not differ significantly at 24 
hours after surgery. Verbal pain scores were similar one week after surgery. 
 
2nd Hypothesis: Preoperative anxiety is associated with postoperative pain and 
preoperatively administered pregabalin can reduce anxiety before surgery. 
(Paper II) 
 
There was a statistical significant positive correlation (p=0.002) between 
preoperative anxiety and postoperative pain at 120 min. When analyzing each 
group separately, the difference was only evident in the pregabalin group 
(p=0.02), whereas in the placebo group no correlation was found (p=0.26). 
However, these were explorative findings as correlation analysis between 
preoperative anxiety and postoperative pain was not planned in the study 
protocol. 
Participants in paper II, who received 150 mg pregabalin about one hour prior to 
surgery reported significantly lower grade of anxiety (VAS) before induction of 
anaesthesia (2.23 ± 1.11 vs. 4.17 ± 2.37, 95%CI: 0.82 to 3.05, p=0.001). 
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3rd Hypothesis: Multimodal antinociceptive treatment with S (+) ketamine or 
pregabalin is not associated with an increased frequency of adverse effects 
(Papers I-II) 
 
Adverse effects were more frequent in patients who were treated with S (+) 
ketamine (paper I). The most frequent reported side effect was diplopia (6 
patients vs. 1 patient; p=0.052). None of the study participants experienced 
hallucinations. The incidence of PONV was equal in both study groups. 
Furthermore, emergence from anaesthesia was significantly longer in the group 
of patients, which was randomized to S (+) ketamine (13.1 min vs. 9.3 min; 
p<0.001). Finally, BIS values were significantly influenced by S (+) ketamine. 
 
Regarding paper II, there was no difference in sedation levels at arrival in the 
PACU. Furthermore, the occurrence of adverse effects in the postoperative 
period was equal in all patients. 
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4th Hypothesis: Local infiltration analgesia (LIA) for total knee replacement can 
reduce postoperative pain and morphine consumption compared to epidural 
analgesia. Furthermore mobilisation can be fastened and the hospital stay can 
be shortened. (Paper III) 
 
In paper III, 102 participants undergoing unilateral total knee arthroplasty were 
enrolled in this randomized study and received either postoperative epidural 
analgesia (EDA) or peri- and postoperative local infiltrations with either local 
(LIA) or IV (LIAiv) ketorolac and morphine. 
 
Verbal pain scores at discharge from PACU were significantly lower in the 
epidural group both at rest and during active knee flexion, but the time to 
discharge from the PACU was delayed (EDA 428 min vs. LIA 327 vs. LIAiv 360 
min; p=0.007).  
After discharge from the PACU the LIA-group had significantly lower pain 
scores (VAS) at rest compared to the EDA-group on day one, two and three 
after surgery. The mean reduction in VAS at rest for the LIA-group compared 
with the EDA-group from discharge PACU until 72 hours after surgery was 7.52, 
95%CI: 2.49 to 12.5, p=0.004. VAS during active knee flexion was significantly 
higher in the EDA-group 72h after surgery compared with patients in the LIA-
group.  
Morphine consumption was lowest in the epidural group during the first day 
after surgery (ns), but thereafter morphine consumption was lowest in the LIA-
group.  
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Patients in both the LIA-group and the LIAiv-group could be mobilized earlier 
after operation. The relative risk of not being able to walk more than 10 meters 
about 48 hours after surgery was 3.5 (95% CI: (1.6, 7.5) for patients 
randomized to the EDA-group compared to the LIA-group and the LIAiv-group. 
Mean time to readiness for hospital discharge was shorter in the LIA-group 
compared to the LIAiv-group and the EDA-group (3.5 ± 0.7 days vs. 4 ± 1.3 
days vs. 5.5 ± 1.6 days; p<0.001). 
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5th Hypothesis: Local infiltration of ketorolac and morphine during total knee 
arthroplasty is more effective than systemic administration of these drugs. 
(Paper III) 
 
There were no differences between the two local infiltration groups during the 
PACU stay. For the time period from the discharge from the postanaesthestic 
care unit until 72 hours after surgery, the mean reduction in VAS for the LIA-
group compared to the LIAiv-group was at rest 5.26, 95%CI: 0.25 to 10.3, 
p=0.040 and during active knee flexion 7.11, 95%CI: -0.23 to 14.5, p=0.058. 
Cumulated morphine consumption during the first 48 hours was lower in the 
LIA-group compared to the LIAiv group (49 ± 36 mg vs. 77 ± 39 mg; p=0.004). 
Mobilisation after surgery and readiness for hospital discharge were similar 
between the two groups. 
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6th Hypothesis: Local infiltration analgesia compared to epidural analgesia is not 
associated with an increased frequency of adverse effects (Paper III) 
 
In paper III, hypotension occurred only in the EDA-group (3 of 33 patients). 
There was no difference between the groups regarding PONV. In five patients, 
the epidural regimen had to be modified less than 4 hours after surgery due to 
insufficient effect. Delayed mobilisation for patients in the epidural group during 
the first postoperative day was mainly due to muscle weakness (6 patients), 
pain (6 patients), dizziness (2 patients) and nausea (4 patients). 
One patient in the study (EDA-group) had to be re-operated after 16 days due 
to knee infection. None of the patients who were treated with local infiltration 
analgesia got knee infection. 
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10. DISCUSSION 
10.1 Discussion of the main findings 
The discussion in this thesis will be divided according to the objectives of the 
thesis with the following main findings: 
 
• The addition of perioperative S (+) ketamine for postoperative analgesia 
after haemorrhoidectomy was not associated with a reduction of 
postoperative pain and low-dose S (+) ketamine on top of a multimodal 
peri- and postoperative pain regimen including dexamethasone and 
ketorolac cannot be recommended 
 
• The administration of perioperative S (+) ketamine was associated with 
an increased frequency of adverse effects 
 
• Preoperative oral administration of a single dose of pregabalin (150 mg) 
before lumbar discectomy showed a reduction in acute postoperative 
pain. Furthermore, morphine consumption during the PACU period was 
decreased without increased incidence of side-effects 
 
• Preoperative anxiety was associated with postoperative pain and one 
capsule with 150 mg pregabalin about one hour prior to surgery resulted 
in a reduction of the grade of anxiety before induction of anaesthesia 
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• Local infiltration analgesia (LIA) with a mixture of ropivacaine, 
epinephrine, ketorolac and morphine reduces postoperative pain and 
opioid consumption after the initial 24 hours compared to epidural 
analgesia in patients undergoing total knee arthroplasty 
 
• Treatment with local infiltration analgesia is not related with an increased 
frequency of adverse effects 
 
• Participants getting local infiltration analgesia compared to epidural 
analgesia can be mobilized faster and are earlier ready for hospital 
discharge 
 
• Local infiltration of ketorolac and morphine during total knee replacement 
is more effective than systemic administration of these drugs regarding 
postoperative pain and morphine consumption 
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Effect of perioperative IV S (+) ketamine on postoperative pain in patients 
scheduled for haemorrhoidectomy (Paper I) 
The effect of subanaesthetic doses of racemic ketamine and S (+) ketamine on 
postoperative pain and opioid consumption has been shown in several 
systematic reviews121-125. However, in our study, when S (+) ketamine was 
added on top of a multimodal analgesic regimen including preoperative 
paracetamol, perioperative dexamethasone, ketorolac and local anaesthetics, 
there was no reduction in postoperative pain scores. Although 
haemorrhoidectomy is known as a painful procedure307, our multimodal 
analgesic approach resulted in a low number of patients complaining about 
moderate to severe pain even in the control group. Kwok et al. showed recently 
that a single dose of racemic ketamine before incision for gynaecologic 
laparoscopy reduced pain scores significantly. However, patients in this study 
received neither paracetamol, steroids, NSAIDs nor local or epidural 
anaesthesia308. In contrast to this, patients undergoing uterine artery 
embolization and receiving adjunctive paracetamol and diclofenac, showed no 
additive effect of racemic ketamine309.  
Another explanation for the absence of an additional analgesic effect of S (+) 
ketamine in our study may be due to low dosage given. Our dosing of S (+) 
ketamine perioperatively was according to recently published 
recommendations113. Adverse effects were observed more frequently in our S 
(+) ketamine group, suggesting that the dose should not be increased further. 
A possible reason for our negative findings may be that we stopped the S (+) 
ketamine infusion at the end of surgery and did not continue S (+) ketamine in 
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the postoperative period as proposed by Lahtinen et al310. However, continued 
S (+) ketamine infusion postoperatively is not practical in the day surgery setting 
with rapid discharge from recovery and rapid mobilization. 
 
Adverse effects of the treatment with S (+) ketamine (Paper I) 
In paper I we found negative clinical effects of S (+) ketamine regarding both 
time for emergence after the end of surgery and the length of stay in the PACU. 
This may be due to the sedative effects of ketamine. A potential confounder 
may be a slightly higher dose of propofol in the S (+) ketamine group, as 
dosage of propofol based on BIS values is more difficult to evaluate when S (+) 
ketamine is used. Several authors have demonstrated the influence of ketamine 
by increasing the BIS values in the past311,312. 
Delay of emergence from anaesthesia increases the need for resources in the 
operation theatre and during the postoperative stay, and this is especially 
unfavourable in day care surgery with a high patient turnover. 
Diplopia shortly after emergence from anaesthesia was more frequent in our 
patient population, which was treated with S (+) ketamine. However, 
impairments of vision were reported as mild and short-lasting and none of the 
study participants reported hallucinations.  
In contrast to our findings, Lahtinen et al observed a significantly increased 
occurrence of major psychotomimetic adverse responses in the patient group 
that was treated with S (+) ketamine310. However, the S (+) ketamine infusion 
was continued for 48 hours after surgery in their study, while S (+) ketamine 
infusion was stopped at the end of surgery in our study. 
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Effects of preoperative pregabalin on postoperative pain and opioid 
consumption in patients undergoing lumbar discectomy (Paper II) 
Several systematic reviews have shown that antihyperalgesic drugs, such as 
gabapentin and pregabalin, can contribute to reduce postoperative pain and 
opioid consumption161-163. Our study results confirm the beneficial effects of 
pregabalin in lumbar disc surgery, as described recently313. Lumbar discectomy 
is usually associated with moderate levels of postoperative pain314 and the use 
of NSAIDs may be controversial in patients undergoing spine surgery, due to 
their possible influence on postoperative bone repair and tissue healing96. 
Therefore the use of pregabalin in these patients may be an alternative to 
NSAIDs.  
In general, postoperative pain is transient somatic pain. However, inflammatory, 
neurogenic and visceral mechanisms may contribute and postoperative pain 
may be defined as a transient type of ‘neuropathic‘ pain160. Surgical procedures 
are always associated with tissue damage. This may result in a local 
inflammatory response and a sensitization of the nociceptors in the periphery. 
As a consequence, transduction and conduction of nociceptive impulses 
towards the CNS may be altered. While traditional antinociceptive drugs reduce 
the afferent input, pregabalin (and gabapentin) may decrease the 
hyperexcitability of dorsal horn neurons, which may be induced by tissue injury 
160. Therefore, the difference in pain intensity between the groups in our study 
may represent an antihyperalgesic effect of pregabalin. 
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Adverse effects of the treatment with pregabalin (Paper II) 
In paper II, we were not able to demonstrate increased sedation levels after 
surgery. In contrast do this, several investigators have described increased 
sedation postoperatively in patients treated with pregabalin166,315. One reason 
for the absence of increased sedation in our study may be the relatively low 
dose of pregabalin (i.e. 150 mg). Other explanations may be low sensitivity in 
our sedation score or the potential sedative effect of higher opioid use in the 
control group during the first postoperative hours, matching a potential sedative 
effect of pregabalin in the other group. 
Dizziness is another side-effect of pregabalin 168,316. However, the frequency of 
dizziness was equal between the patient groups in our study. Again, a possible 
explanation for this may be that the pregabalin dose in our study was only half 
the dose as used in the studies by Hill et al. and White et al., where patients got 
300 mg of pregabalin168,316. 
The incidence of PONV was similar in the whole patient population in our study. 
This is in accordance with the findings of other authors315,317,318. 
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Effects of preoperative pregabalin on preoperative anxiety in patients 
undergoing lumbar discectomy and association of preoperative anxiety 
on postoperative pain (Paper II) 
Our study results determined that anxiety was lower in participants who were 
treated with pregabalin. The anxiolytic effect of pregabalin has been 
demonstrated earlier in a surgical population169, and in a dental anxiety 
model142. However, White et al. recently have published data where pregabalin 
in doses between 75 mg and 300 mg failed to reduce preoperative state of 
anxiety168. The heterogeneity of surgical procedures in the above mentioned 
study and the fact that only patients undergoing short-stay surgery (< 24 hours) 
were included may be a possible explanation for the negative findings of White 
et al. Further studies are needed to confirm the anxiolytic effect of pregabalin. 
Different authors have shown, that the grade of preoperative anxiety is 
associated with the level of postoperative pain27,29. Our results were in 
accordance to this and we found a positive correlation between preoperative 
anxiety and postoperative pain. However, we did not plan such correlation 
analyses when we designed the study protocol and therefore these results 
should be interpreted with caution. Jokela et al. have recently shown that 
pregabalin compared to diazepam is more effective in reducing the intensity of 
postoperative pain, while both drugs are equal when evaluating the level of 
anxiety before anaesthesia319. A possible explanation for these findings may be 
that pregabalin, on one hand, may reduce postoperative pain by lowering 
preoperative anxiety. On the other hand, pregabalin may also independently 
reduce postoperative pain due to its direct antihyperalgesic effects.    
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Effects of local infiltration analgesia (LIA) on postoperative pain and 
opioid consumption compared to epidural analgesia in patients 
undergoing total knee arthroplasty (Paper III) 
Epidural analgesia or continuous peripheral nerve blocks have been 
traditionally recommended as the best postoperative pain treatment after total 
knee arthroplasty231,320-322. In our patient population, epidural analgesia was 
superior to local infiltration analgesia in the early hours after surgery. This may 
be due to the fact that an epidural bolus dose was given just before the spinal 
anaesthesia weared off. However, epidural setup had to be modified due to 
suboptimal analgesia in several patients. Our findings of superior analgesia with 
LIA for observations beyond the first hours are in accordance with Choi et al. 
They conducted a systematic review regarding epidural analgesia versus 
systemic analgesia in patients undergoing knee or hip replacement and 
concluded that the beneficial effect of epidural analgesia on pain relief was 
limited to the early postoperative period231. 
In our study, the pain scores at rest were lower from 24 hours after surgery until 
discharge from the hospital in patients getting LIA with intraarticular ketorolac 
and morphine. These findings are comparable to a recently published study 
where continuous epidural analgesia was compared to local infiltration 
analgesia in patients undergoing total hip arthroplasty323. The authors found 
significantly reduced narcotic consumption and reduced length of stay in 
patients treated with local infiltration analgesia. The same research group 
recently published results of a study were continuous epidural analgesia was 
compared with local infiltration analgesia in patients scheduled for total knee 
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replacement324. The authors concluded that LIA was associated with improved 
pain relief and reduced opioid consumption. In contrast to our study design, 
local infiltration analgesia was administered continuously for 48 hours after 
surgery. Essving and co-workers have recently published a study in TKA 
patients comparing LIA to no injections during surgery and consecutively LIA to 
saline for postoperative intraarticular re-injection203. The results of this study 
showed that LIA provided excellent postoperative pain relief for up to 48 hours 
after total knee replacement as well as lower opioid consumption in the same 
time period. 
 
Effects of local infiltration analgesia (LIA) on postoperative mobilization 
and readiness for hospital discharge compared to epidural analgesia in 
patients undergoing total knee arthroplasty (Paper III) 
The patients in our study who received LIA, either with IV or local ketorolac and 
morphine, had superior knee function and were mobilized faster compared with 
participants who were treated with epidural analgesia. This is in accordance 
with a recently published study on knee arthroplasty patients, were the authors 
demonstrated improved knee flexion for the first 48 hours after surgery in 
patients treated with LIA203. Toftdahl et al. who studied LIA versus femoral 
nerve block in patients undergoing TKA showed that participants treated with 
LIA could walk more than three meters earlier on the first two postoperative 
days.325. Regarding treatment with LIA and readiness for discharge from the 
hospital after major knee surgery, specific discharge criteria are only defined in 
a few studies203,266. Essving et al., who used defined criteria for home 
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readiness, demonstrated that participants who were treated with LIA compared 
to epidural analgesia were significant earlier ready for hospital discharge (3 vs. 
5 days)203. This is in accordance to our findings. 
 
Effects of local infiltration of ketorolac and morphine compared to 
intravenous administration of the same drugs on postoperative pain and 
opioid consumption in patients undergoing TKA (Paper III)  
Participants in our study receiving LIA with locally administrated ketorolac and 
morphine had lower pain scores at rest after discharge from the PACU and 
consumed less morphine during the first 48 hours after surgery compared with 
patients who were treated with intravenous ketorolac and morphine. Therefore, 
we may assume that ketorolac and morphine can have a specific local effect. 
However, some effect of systemic absorption cannot be ruled out with our study 
design. Moreover it is unclear if the analgesic result is based on the effect of 
either ketorolac or morphine or a combination of both drugs.  We used only 
ketorolac, but not morphine, for the re-injection through the knee catheter about 
22-24 hours after surgery. The fact that we observed a significant analgesic 
effect following the knee injection taken into consideration: we may speculate 
that ketorolac plays a key role in the LIA mixture. 
Gupta et al. have conducted a study where they compared the effect of 
morphine or ketorolac with a combination of both drugs in patients scheduled 
for knee arthroscopy326. They found that morphine alone injected intraarticularly 
provided no pain relief, ketorolac alone offered some degree of pain relief and 
the authors concluded that the combination of morphine plus ketorolac provided 
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best analgesia and that the result could be a synergistic effect of these two 
drugs. 
Regarding the local effect of ketorolac, Romsing et al. have conducted a 
systematic review where they investigated the evidence for a peripheral 
analgesic effect of the local infiltration with NSAIDs in postoperative pain327. 
They concluded that intraarticularly administrated NSAIDs might have a 
clinically relevant peripheral action. However, Scott Reuben conducted two of 
the reviewed studies328,329 and one of these two articles was retracted328, which 
may question the conclusion of the meta-analyses. 
Several systematic reviews have been conducted to investigate the analgesic 
effects of intraarticular morphine alone and the results are controversial. While 
Kalso et al.330 and Gupta et al.331 concluded that intraarticular morphine may 
have some effect in reducing postoperative pain and analgesic consumption, 
Rosseland et al. drew the opposite conclusion, that there is no added analgesic 
effect of intraarticularly administrated morphine332. 
The pharmacological differences between IV morphine and IM morphine have 
been described by several authors46,333,334. However, only limited data is 
available regarding the plasma concentration of morphine after intraarticular 
administration, but some drug will diffuse into systemic circulation 335,336. In 
conclusion, the combination of an NSAID (ketorolac) and morphine given locally 
seems to have better efficacy than the same drugs given systemically. 
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Adverse effects of the treatment with epidural analgesia or local 
infiltration analgesia (Paper III) 
In our study (III), hypotension occurred only in patients who were treated with 
epidural analgesia. Choi et al. have conducted a Cochrane review comparing 
epidural analgesia with systemic analgesia and found an odds ratio of 2.78 for 
low blood pressure in the epidural group231. 
Regarding practical problems with epidural analgesia, the majority of all 
procedures to improve epidural analgesia were carried out within 240 minutes 
after end of surgery and in all these patients epidural analgesia became 
adequate after catheter manipulation. Also, spinal anaesthesia lasted longer 
than surgery, and the periods of inadequate epidural treatment was therefore 
relatively short and had probably minor influence on later pain course.  
Suboptimal epidural analgesia due to catheter misplacement or suboptimal 
catheter position is a known problem among anaesthesiologists and is a part of 
the practical aspects of this method in everyday clinics. Literature supports the 
technique of partial catheter withdrawal for better efficacy337. 
Regarding the delayed mobilisation for patients in the epidural group during the 
first postoperative days, this was mainly caused by muscle weakness, dizziness 
and nausea. Muscle weakness of the lower extremities is a known side-effect in 
lumbar epidural analgesia. Dizziness and nausea may be associated with the 
rescue treatment of pain with morphine9. 
Local infiltration analgesia with the insertion of a catheter into the artificial knee 
joint after total knee replacement may theoretically be associated with an 
increased risk of postoperative knee infection. However, by now, none of the 
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published studies investigating the use of LIA in knee arthroplasty has shown 
an increased incidence of knee infections48,202,203,266,324,325,338-345. One patient in 
our study who was treated with epidural analgesia (i.e. no knee injections) was 
re-operated after 16 days due to knee infection. None of the patients who were 
treated with local infiltration analgesia got knee infection. 
However, the overall number of data published on local infiltration analgesia is 
still small and large-scale studies are needed to address potential differences in 
the very low risk of knee infection. Also, the analysis of data from national knee 
arthroplasty registers may be used in the future to increase the knowledge 
about this potential risk. 
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10.2 Strengths and limitations of the studies 
The three studies were conducted in a randomized controlled manner with a 
double blind design when possible. RCTs are considered to be the most reliable 
form of scientific evidence295. 
Furthermore, all studies address research questions from a clinical point of view 
and as a consequence they may be implemented into everyday clinical practice 
and improve patient treatment and patient satisfaction. 
Therefore, preoperative pregabalin (150 mg) is now routinely added to the 
standard premedication for patients undergoing lumbar discectomy at the 
Bærum Hospital. Moreover, local infiltration analgesia with locally applied 
ketorolac and morphine has been established as standard treatment for all 
patients who are scheduled for total knee arthroplasty in our orthopaedic 
department. In contrast to this, perioperative S (+) ketamine is no longer added 
on top of multimodal pain prophylaxis for haemorrhoidectomy. 
 
There are, however, several limitations to our studies. 
Regarding the use of perioperative S (+) ketamine (paper I), all participants 
were treated with a multimodal analgesic regimen including ketorolac, 
dexamethasone and local anaesthetics in the surgical field. This resulted in a 
low number of patients who were complaining about moderate to severe 
postoperative pain in the control group and subsequent difficulties with showing 
any difference with any additional measure. The majority of the studies, 
showing a beneficial effect of subanaesthetic doses of racemic ketamine and S 
(+) ketamine on postoperative pain and opioid consumption, did not use a 
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multimodal postoperative pain management121,123-125. Therefore, the use of low-
dose ketamine or S (+) ketamine may be an alternative in procedures where 
NSAIDs and/or glucocorticoids are contraindicated for some reason or 
controversial due to their possible influence on post-operative bone repair and 
tissue healing. 
 
Regarding the use of premedication with pregabalin (paper II), it is important to 
notice that preoperative anxiety was assessed only by VAS and not by more 
extensive anxiety scales like the Amsterdam Preoperative Anxiety or 
Information Scale (APAIS) or the state component of the State-Trait Anxiety 
Inventory (STAI). However, there is a positive correlation between the VAS and 
the other two psychological tests (APAIS and STAI)303,305. Furthermore, when 
evaluating anxiety short time before the induction of anaesthesia, the use of 
time-consuming tests may be unpractical, whereas the VAS is fast and easy to 
use. 
Another limitation of paper II is the fact that during the PACU period, pain was 
only analysed by VAS at rest and not during movement. The assessment of the 
intensity of acute pain during movement or provocation (dynamic pain) usually 
is a more sensitive tool for detecting differences in post-operative pain228,301. 
However, patient movement was discouraged during the PACU period in our 
patient population due to the believed importance of keeping a stable, resting 
position in the early hours after surgery. 
In paper II, pregabalin was given as a single dose before surgery only and the 
beneficial effects regarding postoperative pain and opioid consumption were 
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only present in the early postoperative period. A prolongation of the analgesic 
effect might have been possible by re-administration of pregabalin about 12 
hours after the initial dose, as recently shown in patients who underwent 
thyroidectomy167. The authors of that study reported reduced verbal pain scores 
at both 24 hours and 48 hours postoperatively following the administration of 
150 mg pregabalin preoperatively and a repeated dose of 150 mg pregabalin 
about 12 hours later. However, sedation was more frequent and more profound 
in patients receiving pregabalin. 
 
Regarding the use of LIA in total knee arthroplasty (paper III), it is important to 
notice that the technique of LIA is not standardized, and different approaches 
have been used in the published studies48,201,265. The amount of infiltrated 
ropivacaine in published studies varies from 200 mg - 400 mg48,201,266. 
Moreover, the addition of adjuvants such as NSAIDs, opioids and epinephrine 
differs in between the studies48,202,325. It is unclear which injection volumes 
should be used and where the injections should be placed (intraarticular vs. 
extraarticular)339. Timing, content and frequency of “top-up” doses through a 
knee catheter is also controversial in the litterature202,203,266. Some authors use 
continuous intraarticular infusions instead of bolus doses267,324. We cannot rule 
out that our results could have been different with different dosing and timing of 
drugs. Further good-quality studies are needed addressing one or a few specific 
items at a time, standardizing the others. 
Another limitation of paper III is the absence of a placebo group. However, 
several double-blinded and randomized studies comparing local infiltration 
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analgesia to placebo in major knee and hip surgery have consistently shown 
that these methods are superior to placebo202,203. Therefore we decided that 
another placebo-controlled study was not needed, also as including placebo 
groups for pain studies of different efficient drugs may be ethically controversial. 
Our study was conducted in a fully double-blind manner regarding patients’ 
randomization to either local or intravenous administered ketorolac and 
morphine. Still, we consider the comparison between the LIA groups and the 
epidural group as potentially un-blinded from the patients’ perspective. 
However, none of the patients were informed about what kind of treatment they 
were randomized to receive. Also, all patients got local skin infiltration analgesia 
before spinal puncture and in the epidural group before epidural puncture, too. 
Patients were informed that they would get spinal anaesthesia and that some 
patients would, in addition, get epidural analgesia. They were not informed in 
details on how many injections in the back they were supposed to feel. 
Postoperative nurse assessments at 240 minutes postoperatively, at discharge 
from PACU and in the whole post-PACU period were done by nurses who were 
not involved in patient treatment and who did not know the group allocation. 
Nevertheless, in spite of dummy catheters and syringe pumps, it is possible that 
some patients and/or researches found out whether true epidural analgesia was 
given or not. 
A general problem with all clinical studies with a low number of standardized 
patients is to have enough statistical power to say anything about differences in 
in-frequent side-effects. This may also be a problem with our studies. According 
to a recently published review about high-volume, local infiltration in major joint 
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replacement, only 14 randomised studies have been conducted regarding total 
knee arthroplasty. All together about 500 patients have been treated with LIA in 
these studies346. Therefore, large-scale studies assessing the safety of this 
method are needed. Moreover, data from national knee arthroplasty and hip 
surgery registers may be of help to get further information regarding the safety 
of LIA. 
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11. SUGGESTIONS FOR FUTURE RESEARCH 
Two of the studies in this thesis have demonstrated that postoperative pain 
management can be improved. However, the study participants still 
experienced pain after surgery and 'pain free' surgery remains the ultimate 
vision.  
 
Only little data are available regarding the use of low-dose ketamine or S (+) 
ketamine in a multimodal postoperative pain management and additional 
studies in this field are needed. Clinical research with ketamine, which is 
focusing on surgical interventions that are usually associated with moderate to 
severe pain, and where the use of NSAIDs and/or glucocorticoids is 
controversial due to their possible influence on post-operative bone repair and 
tissue healing, should be encouraged. 
 
Future research regarding the use of pregabalin should focus on the question 
whether repeated postoperative doses can reduce the intensity of postoperative 
pain for a longer time-period and if this can influence the establishment of 
chronic neuropathic pain states. The correlation between preoperative anxiety 
and postoperative pain, and pregabalins’ effect on this should also be studied 
further. 
 
In the field of local infiltration analgesia, good-quality studies addressing the 
different components in the LIA mixture are needed. There is a great need to 
define289 the optimal LIA cocktail (e.g.,, which drugs and which injection 
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volumes should be used). The necessity of “top-up” doses through a knee 
catheter should be studied further with focus on frequency, timing and content 
of the re-injections. 
Finally, the measurement of plasma concentrations of the locally injected 
agents in LIA versus systemic administration is needed to confirm a real local 
effect of these drugs. 
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12. CONCLUSIONS 
 
• The addition of perioperative S (+) ketamine for postoperative analgesia 
after haemorrhoidectomy on top of a multimodal peri- and postoperative 
pain regimen does not seem to be warranted, due to delayed emergence 
from anaesthesia, more adverse effects and the absence of an additive 
analgesic effect. 
 
• A single dose of pregabalin (150 mg) can reduce postoperative pain at 
rest as well as morphine consumption during the first hours after lumbar 
discectomy. 
 
• A single dose of pregabalin (150 mg) about one hour prior to surgery can 
reduce anxiety before induction of anaesthesia. 
 
• Local infiltration analgesia (LIA) with local adjuvants compared with 
epidural analgesia in total knee arthroplasty can result in reduced post-
operative pain at rest, lower opioid consumption, faster mobilization and 
earlier readiness for hospital discharge. 
 
• Local infiltration of ketorolac and morphine during total knee arthroplasty 
is more efficient than intravenous administration of these drugs regarding 
postoperative pain and morphine consumption. 
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